Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:372-378
Published online before print November 18, 2004, doi: 10.1161/01.ATV.0000151373.33830.41
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v25,p875a)
Right arrow All Versions of this Article:
25/2/372    most recent
01.ATV.0000151373.33830.41v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yasmin,
Right arrow Articles by Wilkinson, I. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yasmin,
Right arrow Articles by Wilkinson, I. B.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:372.)
© 2005 American Heart Association, Inc.


Vascular Biology

Matrix Metalloproteinase-9 (MMP-9), MMP-2, and Serum Elastase Activity Are Associated With Systolic Hypertension and Arterial Stiffness

Yasmin; Sharon Wallace; Carmel M. McEniery; Zahid Dakham; Pawan Pusalkar; Kaisa Maki-Petaja; Mike J. Ashby; John R. Cockcroft; Ian B. Wilkinson

From the Clinical Pharmacology Unit (Y., C.M.M., S.W., Z.D., K.M.-P., M.J.A., I.B.W.), University of Cambridge Addenbrooke’s Hospital Cambridge, United Kingdom; and the Department of Cardiology (P.P., J.R.C.) University of Wales College of Medicine, University Hospital Cardiff, United Kingdom.

Correspondence to Dr Yasmin, Clinical Pharmacology Unit, Addenbrooke’s Hospital, Box 110, Cambridge CB2 2QQ, UK. E-mail my105{at}medschl.cam.ac.uk

Background— Arterial stiffness is an independent determinant of cardiovascular risk, and arterial stiffening is the predominant abnormality in systolic hypertension. Elastin is the main elastic component of the arterial wall and can be degraded by a number of enzymes, including matrix metalloproteinase-9 (MMP-9) and MMP-2. We hypothesized that elastase activity would be related to arterial stiffness and tested this using isolated systolic hypertension (ISH) as a model of stiffening and separately in a large cohort of healthy individuals.

Methods and Results— A total of 116 subjects with ISH and 114 matched controls, as well as 447 individuals free from cardiovascular disease were studied. Aortic and brachial pulse wave velocity (PWV) and augmentation index were determined. Blood pressure, lipids, C-reactive protein, MMP-9, MMP-2, serum elastase activity (SEA), and tissue-specific inhibitor 2 of metalloproteinases were measured. Aortic and brachial PWV, MMP-9, MMP-2, and SEA levels were increased in ISH subjects compared with controls (P=0.001). MMP-9 levels correlated linearly and significantly with aortic (r=0.45; P=0.001) and brachial PWV (r=0.22; P=0.002), even after adjustments for confounding variables. In the younger, healthy subjects, MMP-9 and SEA were also independently associated with aortic PWV.

Conclusions— Aortic stiffness is related to MMP-9 levels and SEA, not only in ISH, but also in younger, apparently healthy individuals. This suggests that elastases including MMP-9 may be involved in the process of arterial stiffening and development of ISH.

The relationship between arterial stiffness and elastase activity was examined in isolated systolic hypertension (ISH), and separately in a large cohort of healthy individuals. Aortic stiffness is related to MMP-9, not only in ISH, but also in healthy individuals, suggesting elastases may be involved in the process of arterial stiffening and the development of ISH.


Key Words: MMP-9 • MMP-2 • elastase activity • pulse wave velocity • augmentation index • elastin




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Bouvet, S. Moreau, J. Blanchette, D. de Blois, and P. Moreau
Sequential Activation of Matrix Metalloproteinase 9 and Transforming Growth Factor {beta} in Arterial Elastocalcinosis
Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 856 - 862.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. R. S. Packard and P. Libby
Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction
Clin. Chem., January 1, 2008; 54(1): 24 - 38.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. A. McAllister, J. D. Maclay, N. L. Mills, G. Mair, J. Miller, D. Anderson, D. E. Newby, J. T. Murchison, and W. MacNee
Arterial Stiffness Is Independently Associated with Emphysema Severity in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., December 15, 2007; 176(12): 1208 - 1214.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Benjo, R. E. Thompson, D. Fine, C. W. Hogue, D. Alejo, A. Kaw, G. Gerstenblith, A. Shah, D. E. Berkowitz, and D. Nyhan
Pulse Pressure Is an Age-Independent Predictor of Stroke Development After Cardiac Surgery
Hypertension, October 1, 2007; 50(4): 630 - 635.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. M.L. Wallace, Yasmin, C. M. McEniery, K. M. Maki-Petaja, A. D. Booth, J. R. Cockcroft, and I. B. Wilkinson
Isolated Systolic Hypertension Is Characterized by Increased Aortic Stiffness and Endothelial Dysfunction
Hypertension, July 1, 2007; 50(1): 228 - 233.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. Tsioufis, K. Dimitriadis, M. Selima, C. Thomopoulos, C. Mihas, I. Skiadas, D. Tousoulis, C. Stefanadis, and I. Kallikazaros
Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients
Eur. Heart J., May 1, 2007; 28(9): 1162 - 1169.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. W. Watts, C. Rondelli, K. Thakali, X. Li, B. Uhal, M. H. Pervaiz, R. E. Watson, and G. D. Fink
Morphological and biochemical characterization of remodeling in aorta and vena cava of DOCA-salt hypertensive rats
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2438 - H2448.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Martos, J. Baugh, M. Ledwidge, C. O'Loughlin, C. Conlon, A. Patle, S. C. Donnelly, and K. McDonald
Diastolic Heart Failure: Evidence of Increased Myocardial Collagen Turnover Linked to Diastolic Dysfunction
Circulation, February 20, 2007; 115(7): 888 - 895.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. D. Schmoker, K. J. McPartland, E. K. Fellinger, J. Boyum, L. Trombley, F. P. Ittleman, C. Terrien III, A. Stanley, and A. Howard
Matrix metalloproteinase and tissue inhibitor expression in atherosclerotic and nonatherosclerotic thoracic aortic aneurysms
J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 155 - 161.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
N Bjarnegard, C Bengtsson, J Brodszki, G Sturfelt, O Nived, and T Lanne
Increased aortic pulse wave velocity in middle aged women with systemic lupus erythematosus
Lupus, October 1, 2006; 15(10): 644 - 650.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Yasmin, C. M. McEniery, K. M. O'Shaughnessy, P. Harnett, A. Arshad, S. Wallace, K. Maki-Petaja, B. McDonnell, M. J. Ashby, J. Brown, et al.
Variation in the Human Matrix Metalloproteinase-9 Gene Is Associated With Arterial Stiffness in Healthy Individuals
Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1799 - 1805.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. H. Ahmed, L. L. Clark, W. R. Pennington, C. S. Webb, D. D. Bonnema, A. H. Leonardi, C. D. McClure, F. G. Spinale, and M. R. Zile
Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases: Relationship Between Changes in Proteolytic Determinants of Matrix Composition and Structural, Functional, and Clinical Manifestations of Hypertensive Heart Disease
Circulation, May 2, 2006; 113(17): 2089 - 2096.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Ye
Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome
Cardiovasc Res, February 15, 2006; 69(3): 636 - 645.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Mahmud and J. Feely
Arterial Stiffness Is Related to Systemic Inflammation in Essential Hypertension
Hypertension, November 1, 2005; 46(5): 1118 - 1122.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Vlachopoulos, I. Dima, K. Aznaouridis, C. Vasiliadou, N. Ioakeimidis, C. Aggeli, M. Toutouza, and C. Stefanadis
Acute Systemic Inflammation Increases Arterial Stiffness and Decreases Wave Reflections in Healthy Individuals
Circulation, October 4, 2005; 112(14): 2193 - 2200.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. E. Tanus-Santos and R. F. Gerlach
Circulating Matrix Metalloproteinase-9 Levels as a Possible Marker of Aortic Stiffness
Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): e127 - e127.
[Full Text] [PDF]


Home page
HypertensionHome page
C. M. McEniery, Yasmin, S. Wallace, K. Maki-Petaja, B. McDonnell, J. E. Sharman, C. Retallick, S. S. Franklin, M. J. Brown, R. C. Lloyd, et al.
Increased Stroke Volume and Aortic Stiffness Contribute to Isolated Systolic Hypertension in Young Adults
Hypertension, July 1, 2005; 46(1): 221 - 226.
[Abstract] [Full Text] [PDF]